The View from Germany: Profiting from Sick Patients

  • by: |
  • 04/08/2009
Yesterday I spotlighted how a recent article in Der Spiegel revealed the burgeoning costs that have already been produced by the latest reforms to the German health care system. Today I want to look at what the article has to say about how the reform has changed the incentives of doctors and sickness funds such that they now profit from making patients as unhealthy as possible – at least on paper.
 
With everyone required to have coverage and premiums fixed nationwide, policy experts in Germany anticipated a problem: sickness funds would look for the healthiest, youngest patients and be reluctant to cover the old or sick. Hence was born the “morbiditätsorientierten Riskoausgleichstruktur,” a mouthful that translates to “morbidity oriented risk adjustment structure” and a concept Germany has in common with countries like the Netherlands, another system sometimes held up as a model for the US.
 
However, although it set out to solve a real problem, it has created a new problem in the process. Since sickness funds get extra money for those with health problems included on the national list (about 80 at the moment), they have an incentive to seek out people with these conditions and to push patients who may be better served by a less serious diagnosis onto these categories. Consider the case of Jens Luther:
 

The 55 year old jogs, rides a racing bike, and eats carefully. As a result, he lives an almost pain free life. He is only occasionally afflicted with a sour stomach, for which each time his doctor prescribes a medicine against heartburn.
         
But with the health care reform, Luther’s condition has worsened considerably. His heart burn grew into a life-threatening reflux disease. The wiry top manager has become chronically ill.

Luther himself hasn’t noticed his terrible pain at all. He looks as fit as anyone; he’s doing great. And if he wasn’t the chairman of the board of the same sickness fund by which he is covered as a patient, he might never have found out that his health situation had deteriorated so dramatically.
 
This kind of reclassification is especially common because the extra the sickness funds receive often exceeds that they spend on care for the condition. For Luther, the sickness fund would get €1079 a year if he was healthy – but the diagnosis of reflux brings an extra €912 a year, even if his actual illness only costs a couple trips to the doctor and some simple prescriptions. The sickness fund then gets to keep the extra money. Der Spiegel reports that this is the case for many illnesses:

High blood pressure brings a bonus of €402 a year. Subtracted from that are average costs of €141 for two appointments with the primary care physician…and medicine (beta blockers, a tablet a day) – making a positive extra premium of €261 under the line.  

An asthma patient, who goes to the pneumonologist every second quarter and uses the conventional combination spray, provides a plus of €192 a year.

The diagnosis ‘psychological depression’ brings the sickness fund nothing. It’s better when the insured has a ‘light depressive episode,’ then there is almost €1000 extra.
 
So the sickness funds encourage doctors to look for patients who can be diagnosed with an illness that brings an extra premium, and share the profits, while people with conditions not on the government list are out of luck. Nor is there any incentive any longer to improve the health of those who are sick or at risk of becoming so. As Luther put it, “It’s totally absurd when the sickness funds have a bigger interest in the sick than in the healthy.”
 
You can find more information on the structure of German health care system at Biggovhealth.org, the international health care site of the Center for Medicine in the Public Interest (the public policy institute home of drugwonks.com).

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog